![]() ![]() There were significant posttreatment differences in metabolites in the left cerebellum between the two groups (myoinositol: JTW, 13.47 ± 2.094 vs. Serum melatonin was increased in patients with ISDHK after JTW treatment (JTW, 339.09 ± 256.894 vs. Higher CGI and lower DHKSS scores were observed after JTW treatment. However, no PSG changes were observed between the two groups ( p > 0.05). Symptom relief was more apparent in the JTW group than the placebo group (PSQI total score: 9.34 ± 3.578 vs. Results: A total of 106 participants completed this clinical trial. All data were collected at baseline and posttreatment. Laboratory tests were used to evaluate the safety of JTW. Pittsburgh Sleep Quality Index (PSQI) scores were set as the primary outcome, and polysomnography (PSG), 1H-magnetic resonance spectroscopy ( 1H-MRS), blood tests, and Disharmony of Heart and Kidney Scoring System (DHKSS) and clinical global impression (CGI) scores were used as secondary outcomes. for 7 days) or placebo group (2-g placebo granules, b.i.d. All participants were equally and randomly divided into either the JTW group (2-g JTW granules, b.i.d. Methods: From September 2018 to February 2020, 128 participants with ISDHK were included in this single-center clinical trial. This study aimed to evaluate the effectiveness and safety of JTW for treating ISDHK in a double-blind, randomized, placebo-controlled trial.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |